Editorial Board
Dajun Deng
Peking University Cancer Hospital and Institute · China
Editorial leadership for Journal of Neoplasms ISSN 2639-1716
Research interests
- Epigenetics
- Carcinogenesis
- Biomarkers
- Precancerous Lesions
- Stomach
Biography
Educations:
- 1978-1983: Undergraduate, Jiangxi Medical College, Medicine, M.D.
- 1983-1986: Graduate, Peking Union Medical College, Oncology, Master of Science
Employments:
- 1986-1998, Research Assistant/Associate, Beijing Institute for Cancer Research
- 1998-present, Professor, Peking University Cancer Hospital and Institute
- 2001-2002, Visiting Research Associate, University of Virginia Health Science Center, Charlottesville, Virginia, USA
Selected publications
- MALAT1–miR663a negative feedback loop in colon cancer cell functions through direct miRNA–lncRNA binding 2018 cited 58×
- RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy 2020 cited 32×
- P16 Methylation as an Early Predictor for Cancer Development From Oral Epithelial Dysplasia: A Double-blind Multicentre Prospective Study 2015 cited 30×
- TTC22 promotes m6A-mediated WTAP expression and colon cancer metastasis in an RPL4 binding-dependent pattern 2022 cited 26×
- P16 methylation increases the sensitivity of cancer cells to the CDK4/6 inhibitor palbociclib 2019 cited 23×
- Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells 2020 cited 21×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JN for your work?
This journal is guided by Dajun Deng (Peking University Cancer Hospital and Institute) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.